Robert L. Erwin is co-founder and President of the Marti Nelson Cancer Foundation, a cancer patient advocacy organization with a focus on access to experimental medicine. He has served as a member of the Cancer Policy Forum of the Institute of Medicine, a member of the Research Committee of the American Society of Clinical Oncology, a member of the Data and Safety Monitoring Board of NCI’s Cancer and Leukemia Group B, and has been a clinical development advisor to the California Institute for Regenerative Medicine. Mr. Erwin is President of iBio, Inc., a public biotech company and serves on the boards of directors of three private companies, Novici Biotech, Oryn Therapeutics, and Expanesthetics, Inc.